DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: cancer treatment

News

Gilead to pay $12 Billion for Kite Pharma

04.09.2017 - US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...

News

UK Said Cutting Costs for Expensive Drugs

30.01.2017 - About 20% of all new drugs will be rationed under tighter cost-cutting plans in the UK’s National Service (NHS), according to reports, which suggest that patients who suffer from...

News

Proteros Signs Second Oncology Collaboration with MSD

20.12.2016 - Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

Bind and Pfizer in Tumor License Deal

28.09.2015 - US pharmaceutical giant Pfizer has exercised its option under the companies’ global collaboration agreement to take an exclusive license from Bind Therapeutics for the purpose of...

News

Merck KGaA and MorphoSys in Joint Antibody R&D

13.06.2014 - Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...

News

Adaptimmune in Cancer Collaboration With GlaxoSmithKline

05.06.2014 - Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...

News

AstraZeneca Plans Spin-offs and Announces Cancer Progress

25.04.2014 - AstraZeneca has unveiled plans to sell or partner infection and neuroscience units with combined 2013 sales of $3.5 billion and a basis in antibiotics and antipsychotics as well as...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.